These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8751951)

  • 21. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media.
    Faden H; Hong J; Murphy T
    Infect Immun; 1992 Sep; 60(9):3824-9. PubMed ID: 1500191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.
    Murphy TF; Bartos LC
    Infect Immun; 1989 Oct; 57(10):2938-41. PubMed ID: 2476393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies.
    Yang YP; Myers LE; McGuinness U; Chong P; Kwok Y; Klein MH; Harkness RE
    FEMS Immunol Med Microbiol; 1997 Mar; 17(3):187-99. PubMed ID: 9093840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.
    Meier PS; Freiburghaus S; Martin A; Heiniger N; Troller R; Aebi C
    Pediatr Infect Dis J; 2003 Mar; 22(3):256-62. PubMed ID: 12634588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate.
    Chen D; McMichael JC; VanDerMeid KR; Masi AW; Bortell E; Caplan JD; Chakravarti DN; Barniak VL
    Vaccine; 1999 Aug; 18(1-2):109-18. PubMed ID: 10501241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.
    Augustyniak D; Seredyński R; McClean S; Roszkowiak J; Roszniowski B; Smith DL; Drulis-Kawa Z; Mackiewicz P
    Sci Rep; 2018 Mar; 8(1):4955. PubMed ID: 29563531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a hemin utilization protein of Moraxella catarrhalis (HumA).
    Furano K; Campagnari AA
    Infect Immun; 2004 Nov; 72(11):6426-32. PubMed ID: 15501773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis.
    Sethi S; Surface JM; Murphy TF
    Infect Immun; 1997 Sep; 65(9):3666-71. PubMed ID: 9284135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin.
    Aebi C; Stone B; Beucher M; Cope LD; Maciver I; Thomas SE; McCracken GH; Sparling PF; Hansen EJ
    Infect Immun; 1996 Jun; 64(6):2024-30. PubMed ID: 8675303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.
    Chen D; McMichael JC; VanDerMeid KR; Hahn D; Mininni T; Cowell J; Eldridge J
    Infect Immun; 1996 Jun; 64(6):1900-5. PubMed ID: 8675285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors.
    Luke NR; Campagnari AA
    Infect Immun; 1999 Nov; 67(11):5815-9. PubMed ID: 10531234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model.
    Murphy TF; Kyd JM; John A; Kirkham C; Cripps AW
    J Infect Dis; 1998 Dec; 178(6):1667-75. PubMed ID: 9815219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis.
    Bonnah RA; Yu RH; Wong H; Schryvers AB
    Microb Pathog; 1998 Feb; 24(2):89-100. PubMed ID: 9480791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants.
    Murphy TF; Brauer AL; Yuskiw N; Hiltke TJ
    Infect Immun; 2000 Nov; 68(11):6250-6. PubMed ID: 11035732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein.
    Boel E; Bootsma H; de Kruif J; Jansze M; Klingman KL; van Dijk H; Logtenberg T
    Infect Immun; 1998 Jan; 66(1):83-8. PubMed ID: 9423843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moraxella catarrhalis: a review of an important human mucosal pathogen.
    Karalus R; Campagnari A
    Microbes Infect; 2000 Apr; 2(5):547-59. PubMed ID: 10865200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.
    Chen D; Barniak V; VanDerMeid KR; McMichael JC
    Infect Immun; 1999 Mar; 67(3):1310-6. PubMed ID: 10024576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.
    Murphy TF; Kirkham C; Liu DF; Sethi S
    Infect Immun; 2003 Mar; 71(3):1288-94. PubMed ID: 12595444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.
    Ren D; Almudevar AL; Murphy TF; Lafontaine ER; Campagnari AA; Luke-Marshall N; Pichichero ME
    Vaccine; 2019 Jul; 37(32):4637-4645. PubMed ID: 28755833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.